Literature DB >> 11363758

FDA approves cidofovir for treatment of CMV retinitis. Food and Drug Administration.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 11363758

Source DB:  PubMed          Journal:  J Int Assoc Physicians AIDS Care        ISSN: 1081-454X


× No keyword cloud information.
  5 in total

Review 1.  BK polyomavirus: emerging pathogen.

Authors:  Shauna M Bennett; Nicole M Broekema; Michael J Imperiale
Journal:  Microbes Infect       Date:  2012-02-24       Impact factor: 2.700

2.  Correlation between cidofovir-associated uveitis and failing immunorestoration during HAART.

Authors:  E Tacconelli; M Tumbarello; R Rabagliati; G Scoppettuolo; A Minnella; G Ventura; R Cauda
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-02-15       Impact factor: 3.267

3.  Effect of Leflunomide, Cidofovir and Ciprofloxacin on replication of BKPyV in a salivary gland in vitro culture system.

Authors:  Liesl K Jeffers-Francis; Raquel Burger-Calderon; Jennifer Webster-Cyriaque
Journal:  Antiviral Res       Date:  2015-03-16       Impact factor: 5.970

Review 4.  Efficacy of CMX001 as a prophylactic and presymptomatic antiviral agent in New Zealand white rabbits infected with rabbitpox virus, a model for orthopoxvirus infections of humans.

Authors:  Amanda D Rice; Mathew M Adams; Bernhard Lampert; Scott Foster; Alice Robertson; George Painter; Richard W Moyer
Journal:  Viruses       Date:  2011-02       Impact factor: 5.048

Review 5.  Efficacy of CMX001 as a post exposure antiviral in New Zealand White rabbits infected with rabbitpox virus, a model for orthopoxvirus infections of humans.

Authors:  Amanda D Rice; Mathew M Adams; Greg Wallace; Andrew M Burrage; Scott F Lindsey; Andrew J Smith; Daniele Swetnam; Brandi R Manning; Stacey A Gray; Bernhard Lampert; Scott Foster; Randall Lanier; Alice Robertson; George Painter; Richard W Moyer
Journal:  Viruses       Date:  2011-01       Impact factor: 5.048

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.